Guanylate Cyclase (GUCA) Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $47.00 $105.00 $322.00 | 45 | |
Inhibits nitric oxide synthase (NOS), which can indirectly affect guanylate cyclase activity, and hence Guanylate Cyclase Activator (GUCA) function. | ||||||
ODQ | 41443-28-1 | sc-200325 sc-200325A | 10 mg 50 mg | $76.00 $218.00 | 13 | |
A soluble guanylate cyclase inhibitor. By inhibiting guanylate cyclase, ODQ can indirectly modulate the actions of Guanylate Cyclase Activator (GUCA). | ||||||
Riociguat | 625115-55-1 | sc-476845 | 5 mg | $300.00 | ||
It is a direct stimulator of soluble guanylate cyclase (sGC), used for pulmonary hypertension. It can provide insights into sGC signaling pathways. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $42.00 $102.00 $322.00 | 3 | |
Acts on guanylate cyclase, reducing its activity and hence indirectly influencing Guanylate Cyclase Activator (GUCA). | ||||||
Aceclofenac | 89796-99-6 | sc-217557 | 10 mg | $98.00 | ||
Inhibits guanylate cyclase activity, thereby having potential indirect effects on Guanylate Cyclase Activator (GUCA) function. | ||||||
KT5823 | 126643-37-6 | sc-3534 sc-3534A sc-3534B | 100 µg 1 mg 5 mg | $178.00 $1204.00 $4799.00 | 21 | |
Protein kinase G inhibitor. As Guanylate Cyclase Activator (GUCA)'s role in guanylate cyclase activation can influence cGMP and PKG activity, inhibiting PKG can indirectly influence Guanylate Cyclase Activator (GUCA)-associated signaling. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Acts as a PDE1 inhibitor, preventing the breakdown of cGMP. This can influence the balance of cGMP in the cell and indirectly modulate Guanylate Cyclase Activator (GUCA)'s function. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
A PDE5 inhibitor which affects cGMP levels. By modulating cGMP concentrations, Zaprinast can indirectly influence Guanylate Cyclase Activator (GUCA)-associated functions. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $176.00 | 13 | |
PDE5 inhibitor affecting cGMP concentrations. This alteration in cGMP can indirectly have effects on Guanylate Cyclase Activator (GUCA)'s role in the pathway. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $516.00 $720.00 $16326.00 | 7 | |
Another PDE5 inhibitor impacting cGMP levels. By doing so, it can indirectly modulate the activities where Guanylate Cyclase Activator (GUCA) is involved. | ||||||